vtioВестник трансплантологии и искусственных органовRussian Journal of Transplantology and Artificial Organs1995-1191Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation10.15825/1995-1191-2023-2-15-25vtio-1603Research ArticleКлиническая трансплантологияClinical TransplantologyВыбор метода лечения симптоматической инфравезикальной обструкции У пациентов С доброкачественной гиперплазией предстательной железы, перенесших трансплантацию почкиChoice Of treatment method for symptomatic Bladder outlet obstruction in patients with benign prostatic hyperplasia after kidney transplantationПоповС. В.PopovS. V.

Сергей Валерьевич Попов

Санкт-Петербург

St. Petersburg

info@lucaclinic.ruГусейновР. Г.HuseynovR. G.

Руслан Гусейнович Гусейнов

Санкт-Петербург

St. Petersburg

info@lucaclinic.ruСайдулаевД. А.SaydulaevD. A.

Москва

Moscow

priemtranspl@yandex.ruСадовниковС. В.SadovnikovS. V.

Москва

Moscow

priemtranspl@yandex.ruКисильЮ. В.KisilYu. V.

Санкт-Петербург

St. Petersburg

info@lucaclinic.ruСивакК. В.SivakK. V.

Константин Владимирович Сивак

Санкт-Петербург

St. Petersburg

kvsivak@gmail.comБуненковН. С.BunenkovN. S.

Николай Сергеевич Буненков

Санкт-Петербург

St. Petersburg

bunenkov2006@gmail.comПерепелицаВ. В.PerepelitsaV. V.

Санкт-Петербург

St. Petersburg

perepelitsa_vit@mail.ruУлитинаА. С.UlitinaA. S.

Анна Сергеевна Улитина

Санкт-Петербург

St. Petersburg

anna.s.ulitina@yandex.ruЛелявинаТ. А.LelyavinaT. A.

Лелявина Татьяна Александровна

197341, Санкт-Петербург, ул. Аккуратова, д. 2. Тел. (981) 908-90-18

Tatiana Lelyavina

2, Akkuratova str., St. Petersburg, 197341, Phone: (981) 908-90-18

tatianalelyavina@mail.ruСПб ГБУЗ «Клиническая больница Святителя Луки»РоссияSt. Luke’s Clinical HospitalRussian FederationСПб ГБУЗ «Клиническая больница Святителя Луки»; Санкт-Петербургский государственный университетРоссияSt. Luke’s Clinical Hospital; St. Petersburg State UniversityRussian FederationФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава РоссииРоссияShumakov National Medical Research Center of Transplantology and Artificial OrgansRussian FederationСПб ГБУЗ «Клиническая больница Святителя Луки»; ФБГОУ ВО «Первый Санкт-Петербургский государственный медицинский университет имени И.П. Павлова»; ФГБУ «Национальный медицинский исследовательский центр имени В.А. Алмазова» Минздрава РоссииRussian FederationSt. Luke’s Clinical Hospital; Pavlov University; Almazov National Medical Research CentreRussian FederationСПб ГБУЗ «Клиническая больница Святителя Луки»; ФБГОУ ВО «Первый Санкт-Петербургский государственный медицинский университет имени И.П. Павлова»РоссияSt. Luke’s Clinical Hospital; Pavlov UniversityRussian FederationФГБУ «Национальный медицинский исследовательский центр имени В.А. Алмазова» Минздрава РоссииРоссияAlmazov National Medical Research CentreRussian Federation2023150720232521525Copyright © Попов С.В., Гусейнов Р.Г., Сайдулаев Д.А., Садовников С.В., Кисиль Ю.В., Сивак К.В., Буненков Н.С., Перепелица В.В., Улитина А.С., Лелявина Т.А., 20232023Попов С.В., Гусейнов Р.Г., Сайдулаев Д.А., Садовников С.В., Кисиль Ю.В., Сивак К.В., Буненков Н.С., Перепелица В.В., Улитина А.С., Лелявина Т.А.Popov S.V., Huseynov R.G., Saydulaev D.A., Sadovnikov S.V., Kisil Y.V., Sivak K.V., Bunenkov N.S., Perepelitsa V.V., Ulitina A.S., Lelyavina T.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.transpl.ru/vtio/article/view/1603

Статья посвящена сравнительной оценке различных методов лечения симптоматической инфравезикальной обструкции (ИВО) у пациентов с доброкачественной гиперплазией предстательной железы (ДГПЖ), перенесших трансплантацию почки (ТП).

St. Petersburg, Russian Federation The paper presents a comparative assessment of different methods of treating symptomatic bladder outlet obstruction (BOO) in patients with benign prostatic hyperplasia (BPH) who underwent kidney transplantation (KT).

инфравезикальная обструкциядоброкачественная гиперплазия предстательной железытрансплантация почкиbladder outlet obstructionbenign prostatic hyperplasiakidney transplantationReferencesГодовой отчет о трансплантологии в Европе за 2019 год. https://www.eurotransplant.org/wp-content/uploads/2020/06/AnnualReport-2019.pdf.Godovoy otchet o transplantologii v Evrope za 2019 god. https://www.eurotransplant.org/wp-content/uploads/2020/06/AnnualReport-2019.pdf.Готье СВ, Хомяков СМ. Донорство и трансплантация органов в Российской Федерации в 2018 году. XII сообщение Российского трансплантологического общества. Вестник трансплантологии и искусственных органов. 2019; 21 (3): 7–32. https://doi.org/10.15825/1995-1191-2019.Gautier SV, Khomyakov SM. Donorstvo i transplantatsiya organov v Rossiyskoy Federatsii v 2018 godu. XII soobshchenie Rossiyskogo transplantologicheskogo obshchestva. Vestnik transplantologii i iskusstvennykh organov. 2019; 21 (3): 7–32. https://doi.org/10.15825/1995-1191-2019.Кабанова СА, Богопольский ПМ. Пересадка почки: история, итоги и перспективы. Трансплантология. 2015; (2): 49–58.4. Султанов ПК, Хаджибаев ФА, Эргашев ДН, Исматов АА. Анализ осложнений после трансплантации почки. Вестник экстренной медицины. 2021; 14 (1): 55–63.Султанов ПК, Хаджибаев ФА, Эргашев ДН, Исматов АА. Анализ осложнений после трансплантации почки. Вестник экстренной медицины. 2021; 14 (1): 55–63.Sultanov PK, Khadzhibaev FA, Ergashev DN, Ismatov AA. Analiz oslozhneniy posle transplantatsii pochki. Vestnik ekstrennoy meditsiny. 2021; 14 (1): 55–63.Dos Santos Mantovani M, Coelho de Carvalho N, Archangelo TE, Modelli de Andrade LG, Pires Ferreira Filho S, de Souza Cavalcante R et al. Frailty predicts surgical complications after kidney transplantation. A propensity score matched study. PLoS One. 2020 Feb 26; 15 (2): e0229531.Dos Santos Mantovani M, Coelho de Carvalho N, Archangelo TE, Modelli de Andrade LG, Pires Ferreira Filho S, de Souza Cavalcante R et al. Frailty predicts surgical complications after kidney transplantation. A propensity score matched study. PLoS One. 2020 Feb 26; 15 (2): e0229531.Bessede T, Hammoudi Y, Bedretdinova D, Parier B, Francois H, Durrbach A, Benoit G. Preoperative Risk Factors Associated With Urinary Complications After Kidney Transplantation. Transplant Proc. 2017 Nov; 49 (9): 2018–2024.Bessede T, Hammoudi Y, Bedretdinova D, Parier B, Francois H, Durrbach A, Benoit G. Preoperative Risk Factors Associated With Urinary Complications After Kidney Transplantation. Transplant Proc. 2017 Nov; 49 (9): 2018–2024.Hickman LA, Sawinski D, Guzzo T, Locke JE. Urologic malignancies in kidney transplantation. Am J Transplant. 2018 Jan; 18 (1): 13–22.Hickman LA, Sawinski D, Guzzo T, Locke JE. Urologic malignancies in kidney transplantation. Am J Transplant. 2018 Jan; 18 (1): 13–22.Shimizu T, Sugihara T, Kamei J, Takeshima S, Kinoshita Y, Kubo T et al. Predictive factors and management of urinary tract infections after kidney transplantation: a retrospective cohort study. Clin Exp Nephrol. 2021 Feb; 25 (2): 200–206.Shimizu T, Sugihara T, Kamei J, Takeshima S, Kinoshita Y, Kubo T et al. Predictive factors and management of urinary tract infections after kidney transplantation: a retrospective cohort study. Clin Exp Nephrol. 2021 Feb; 25 (2): 200–206.Thuret R, Timsit MO, Kleinclauss F. Chronic kidney disease and kidney transplantation. Prog Urol. 2016 Nov; 26 (15): 882–908.Thuret R, Timsit MO, Kleinclauss F. Chronic kidney disease and kidney transplantation. Prog Urol. 2016 Nov; 26 (15): 882–908.Billis A, Freitas LLL, Costa LBE, Barreto IS, Botega AAR, Pereira TA, D’Ancona CA. Lower Urinary Tract Symptoms Due to Xanthoma of the Prostate After Kidney Transplantation: A Case Report. Transplant Proc. 2020 Nov; 52 (9): 2736–2738.Billis A, Freitas LLL, Costa LBE, Barreto IS, Botega AAR, Pereira TA, D’Ancona CA. Lower Urinary Tract Symptoms Due to Xanthoma of the Prostate After Kidney Transplantation: A Case Report. Transplant Proc. 2020 Nov; 52 (9): 2736–2738.Frascà GM, Brigante F, Volpe A, Cosmai L, Gallieni M, Porta C. Kidney transplantation in patients with previous renal cancer: a critical appraisal of current evidence and guidelines. J Nephrol. 2019 Feb; 32 (1): 57–64.Frascà GM, Brigante F, Volpe A, Cosmai L, Gallieni M, Porta C. Kidney transplantation in patients with previous renal cancer: a critical appraisal of current evidence and guidelines. J Nephrol. 2019 Feb; 32 (1): 57–64.Tan JHS, Bhatia K, Sharma V, Swamy M, van Dellen D, Dhanda R, Khambalia H. Enhanced recovery after surgery recommendations for renal transplantation: guidelines. Br J Surg. 2022 Dec 13; 110 (1): 57–59.Tan JHS, Bhatia K, Sharma V, Swamy M, van Dellen D, Dhanda R, Khambalia H. Enhanced recovery after surgery recommendations for renal transplantation: guidelines. Br J Surg. 2022 Dec 13; 110 (1): 57–59.Thuret R, Kleinclauss F, Terrier N, Karam G, Timsit MO. Challenges in renal transplantation. Prog Urol. 2016 Nov; 26 (15): 1001–1044. 14. Maggiore U, Abramowicz D, Budde K. Renal transplantation in the elderly. Transplant Rev (Orlando). 2015 Oct; 29 (4): 191–192.Thuret R, Kleinclauss F, Terrier N, Karam G, Timsit MO. Challenges in renal transplantation. Prog Urol. 2016 Nov; 26 (15): 1001–1044. 14. Maggiore U, Abramowicz D, Budde K. Renal transplantation in the elderly. Transplant Rev (Orlando). 2015 Oct; 29 (4): 191–192.Rodríguez Faba O, Boissier R, Budde K, Figueiredo A, Taylor CF, Hevia V et al. European Association of Urology Guidelines on Renal Transplantation: Update 2018. Eur Urol Focus. 2018 Mar; 4 (2): 208–215.Rodríguez Faba O, Boissier R, Budde K, Figueiredo A, Taylor CF, Hevia V et al. European Association of Urology Guidelines on Renal Transplantation: Update 2018. Eur Urol Focus. 2018 Mar; 4 (2): 208–215.Cheung CY, Tang SCW. An update on cancer after kidney transplantation. Nephrol Dial Transplant. 2019 Jun 1; 34 (6): 914–920.Cheung CY, Tang SCW. An update on cancer after kidney transplantation. Nephrol Dial Transplant. 2019 Jun 1; 34 (6): 914–920.Egan KB. The epidemiology of benign prostatic hyperplasia associated with lower urinary tractsymptoms: prevalence and incident rates. Urol Clin North Am. 2016; 43: 289.Egan KB. The epidemiology of benign prostatic hyperplasia associated with lower urinary tractsymptoms: prevalence and incident rates. Urol Clin North Am. 2016; 43: 289.De Oliveira Marinho AC, Tavares­da­Silva E, Bastos CA, Roseiro A, Parada B, Retroz E et al. Acute Urinary Retention After Kidney Transplant: Effect on Graft Function, Predictive Factors, and Treatment. Transplant Proc. 2021 Jul-Aug; 53 (6): 1933–1938.De Oliveira Marinho AC, Tavares­da­Silva E, Bastos CA, Roseiro A, Parada B, Retroz E et al. Acute Urinary Retention After Kidney Transplant: Effect on Graft Function, Predictive Factors, and Treatment. Transplant Proc. 2021 Jul-Aug; 53 (6): 1933–1938.Sarier M, Yayar O, Yavuz A, Turgut H, Kukul E. Update on the Management of Urological Problems Following Kidney Transplantation. Urol Int. 2021; 105 (7–8): 541–547.Sarier M, Yayar O, Yavuz A, Turgut H, Kukul E. Update on the Management of Urological Problems Following Kidney Transplantation. Urol Int. 2021; 105 (7–8): 541–547.Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK et al. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I – Initial Work-up and Medical Management. J Urol. 2021 Oct; 206 (4): 806–817.Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK et al. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I – Initial Work-up and Medical Management. J Urol. 2021 Oct; 206 (4): 806–817.Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK et al. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART II – Surgical Evaluation and Treatment. J Urol. 2021 Oct; 206 (4): 818–826.Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK et al. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART II – Surgical Evaluation and Treatment. J Urol. 2021 Oct; 206 (4): 818–826.Касян ГР, Ходырева ЛА, Дударева АА и др. Комбинированное лечение симптомов нижних мочевых путей у мужчин. Медицинский совет. 2016; 5: 84–90.Kasyan GR, Khodyreva LA, Dudareva AA i dr. Kombinirovannoe lechenie simptomov nizhnikh mochevykh putey u muzhchin. Meditsinskiy sovet. 2016; 5: 84–90.Seo JH, Han JS, Lee Y, Myong JP, Ha US. Fall risk related to subtype-specific alpha-antagonists for benign prostatic hyperplasia: a nationwide Korean populationbased cohort study. World J Urol. 2022 Dec; 40 (12): 3043–3048.Seo JH, Han JS, Lee Y, Myong JP, Ha US. Fall risk related to subtype-specific alpha-antagonists for benign prostatic hyperplasia: a nationwide Korean populationbased cohort study. World J Urol. 2022 Dec; 40 (12): 3043–3048.Пушкарь ДЮ, Раснер ПИ, Харчилава РР. Российские клинические рекомендации с современными данными ведущих российских специалистов. Симптомы нижних мочевыводящих путей и доброкачественная гиперплазия предстательной железы. Урология. 2016; (2, прилож.): 4–19.Pushkar’ DYu, Rasner PI, Kharchilava RR. Rossiyskie klinicheskie rekomendatsii s sovremennymi dannymi vedushchikh rossiyskikh spetsialistov. Simptomy nizhnikh mochevyvodyashchikh putey i dobrokachestvennaya giperplaziya predstatel’noy zhelezy. Urologiya. 2016; (2, prilozh.): 4–19.Раснер ПИ, Газимиев МА, Гаджиева ЗК и др. Расстройства мочеиспускания у мужчин: методические рекомендации, № 6. М.: АБВ-пресс, 2017; 35.Rasner PI, Gazimiev MA, Gadzhieva ZK i dr. Rasstroystva mocheispuskaniya u muzhchin: metodicheskie rekomendatsii, № 6. M.: ABV-press, 2017; 35.Павлов ВН, Галимзянов ВЗ, Казихинуров АА, Пушкарев АМ, Загитов АР, Казихинурова АА, Шарипов ИР. Симптомы нижних мочевыводящих путей и доброкачественная гиперплазия предстательной железы: учебное пособие. Уфа: БГМУ, 2018; 86.Pavlov VN, Galimzyanov VZ, Kazikhinurov AA, Pushkarev AM, Zagitov AR, Kazikhinurova AA, Sharipov IR. Simptomy nizhnikh mochevyvodyashchikh putey i dobrokachestvennaya giperplaziya predstatel’noy zhelezy: uchebnoe posobie. Ufa: BGMU, 2018; 86.Foster HE, Dahm P, Kohler TS et al. Surgical management of lower urinary tract symptom sattributed to benign prostatic hyperplasia: AUA Guideline amendment 2019. J Urol. 2019; 202: 592.Foster HE, Dahm P, Kohler TS et al. Surgical management of lower urinary tract symptom sattributed to benign prostatic hyperplasia: AUA Guideline amendment 2019. J Urol. 2019; 202: 592.Marks LS, Gittelman MC, Hill LA, Volinn W, Hoel G. Rapid efficacy of the highly selective α1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies. J Urol. 2013; 189 (1 Suppl): S122–S128.Marks LS, Gittelman MC, Hill LA, Volinn W, Hoel G. Rapid efficacy of the highly selective α1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies. J Urol. 2013; 189 (1 Suppl): S122–S128.Homma Y, Kawabe K, Tsukamoto T et al. Estimate criteria for diagnosis and severity in benign prostatic hyperplasia. Int J Urol. 1996; 3: 261–266.Homma Y, Kawabe K, Tsukamoto T et al. Estimate criteria for diagnosis and severity in benign prostatic hyperplasia. Int J Urol. 1996; 3: 261–266.Debruyne F, Boyle P, Calais Da Silva F et al. Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients – PERMAL study subset analysis. Eur Urol. 2004; 45: 773–779.Debruyne F, Boyle P, Calais Da Silva F et al. Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients – PERMAL study subset analysis. Eur Urol. 2004; 45: 773–779.Razek M, Abolyosr A, Mhammed O, Fathi A, Talaat M, Hassan A. Prospective comparison of tadalafil 5 mg alone, silodosin 8 mg alone, and the combination of both in treatment of lower urinary tract symptoms related to benign prostatic hyperplasia. World J Urol. 2022. Aug; 40 (8): 2063–2070.Razek M, Abolyosr A, Mhammed O, Fathi A, Talaat M, Hassan A. Prospective comparison of tadalafil 5 mg alone, silodosin 8 mg alone, and the combination of both in treatment of lower urinary tract symptoms related to benign prostatic hyperplasia. World J Urol. 2022. Aug; 40 (8): 2063–2070.Lukacs B, Grange JC, Comet D. One-year follow-up of 2829 patients with moderate to severe lower urinarytract symptoms treated with alfuzosin in general practice according to IPSS and a health-related quality-of-life questionnaire. BPM Group in General Practice Urology. 2000; 55: 540–546.Lukacs B, Grange JC, Comet D. One-year follow-up of 2829 patients with moderate to severe lower urinarytract symptoms treated with alfuzosin in general practice according to IPSS and a health-related quality-of-life questionnaire. BPM Group in General Practice Urology. 2000; 55: 540–546.Barendrecht MM, Abrams P, Schumacher H, de a Rosette JJ, Michel MC. Do α1-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance? Neurourol Urodyn. 2008; 27: 226–230.Barendrecht MM, Abrams P, Schumacher H, de a Rosette JJ, Michel MC. Do α1-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance? Neurourol Urodyn. 2008; 27: 226–230.Fusco F, Creta M, De Nunzio C et al. Progressive bladder remodeling due to bladder outlet obstruction: a systematic review of morphological and molecular evidences in humans. BMC Urol. 2018; 18: 15.Fusco F, Creta M, De Nunzio C et al. Progressive bladder remodeling due to bladder outlet obstruction: a systematic review of morphological and molecular evidences in humans. BMC Urol. 2018; 18: 15.Gul ZG, Kaplan SA. BPH: why do patients fail medical therapy? Curr Urol Rep. 2019; 20: 40.Gul ZG, Kaplan SA. BPH: why do patients fail medical therapy? Curr Urol Rep. 2019; 20: 40.La Vignera S, Aversa A, Cannarella R, Condorelli RA, Duca Y, Russo GI, Calogero AE. Pharmacological treatment of lower urinary tract symptoms in benign prostatic hyperplasia: consequences on sexual function and possible endocrine effects. Expert Opin Pharmacother. 2021 Feb; 22 (2): 179–189.La Vignera S, Aversa A, Cannarella R, Condorelli RA, Duca Y, Russo GI, Calogero AE. Pharmacological treatment of lower urinary tract symptoms in benign prostatic hyperplasia: consequences on sexual function and possible endocrine effects. Expert Opin Pharmacother. 2021 Feb; 22 (2): 179–189.Alcaraz A, Castro­Díaz D, Gacci M, Salonia A, Ficarra V, Carballido­Rodríguez J et al. Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-toSevere LUTS-BPH Patients: Results of a Paired Matched Clinical Study. On Behalf Of The Qualiprost Study Group. J Clin Med. 2022 Jun 22; 11 (13): 3615.Alcaraz A, Castro­Díaz D, Gacci M, Salonia A, Ficarra V, Carballido­Rodríguez J et al. Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-toSevere LUTS-BPH Patients: Results of a Paired Matched Clinical Study. On Behalf Of The Qualiprost Study Group. J Clin Med. 2022 Jun 22; 11 (13): 3615.Bauer SR, Walter LC, Ensrud KE, Suskind AM, Newman JC, Ricke WA et al. Assessment of Frailty and Association With Progression of Benign Prostatic Hyperplasia Symptoms and Serious Adverse Events Among Men Using Drug Therapy. JAMA Netw Open. 2021 Nov 1; 4 (11): e2134427.Bauer SR, Walter LC, Ensrud KE, Suskind AM, Newman JC, Ricke WA et al. Assessment of Frailty and Association With Progression of Benign Prostatic Hyperplasia Symptoms and Serious Adverse Events Among Men Using Drug Therapy. JAMA Netw Open. 2021 Nov 1; 4 (11): e2134427.Kuzmenko AV, Kuzmenko VV, Gyaurgiev TA. Comparative analysis of the effectiveness of early and delayed initiation of combined DRUG therapy for bph. Urologiia. 2021 May; (2): 27–30.Kuzmenko AV, Kuzmenko VV, Gyaurgiev TA. Comparative analysis of the effectiveness of early and delayed initiation of combined DRUG therapy for bph. Urologiia. 2021 May; (2): 27–30.Gravas S, Cornu JN, Gacci M et al. EAU guidelines on management of non-neurogenic male LUTS. Presented at 2020 EAU Annual Congress, Amsterdam, Arnhem, The Netherlands. Available at http://uroweb.org/guidelines/compilations-of-all-guidelines/.Gravas S, Cornu JN, Gacci M et al. EAU guidelines on management of non-neurogenic male LUTS. Presented at 2020 EAU Annual Congress, Amsterdam, Arnhem, The Netherlands. Available at http://uroweb.org/guidelines/compilations-of-all-guidelines/.Anderson BB, Pariser JJ, Helfand BT. Comparison of Patients Undergoing PVP Versus TURP for LUTS/BPH. Curr Urol Rep. 2015 Aug; 16 (8): 55.Anderson BB, Pariser JJ, Helfand BT. Comparison of Patients Undergoing PVP Versus TURP for LUTS/BPH. Curr Urol Rep. 2015 Aug; 16 (8): 55.Drouin S, Defortescu G, Prudhomme T, Culty T, Verhoest G, Doerfler A et al. Lower urinary tract symptoms and urinary incontinence in renal transplant recipients and candidates: The French guidelines from CTAFU. Prog Urol. 2021 Jan; 31 (1): 45–49.Drouin S, Defortescu G, Prudhomme T, Culty T, Verhoest G, Doerfler A et al. Lower urinary tract symptoms and urinary incontinence in renal transplant recipients and candidates: The French guidelines from CTAFU. Prog Urol. 2021 Jan; 31 (1): 45–49.Checcucci E, Veccia A, De Cillis S, Piramide F, Volpi G, Amparore D et al. New Ultra-minimally Invasive Surgical Treatment for Benign Prostatic Hyperplasia: A Systematic Review and Analysis of Comparative Outcomes. Uro-technology and SoMe Working Group of the Young Academic Urologists Working Party of the European Association of Urology and of the Lower Tract and Research Group of the European Section of Uro-technology. Eur Urol Open Sci. 2021 Sep 22; 33: 28–41.Checcucci E, Veccia A, De Cillis S, Piramide F, Volpi G, Amparore D et al. New Ultra-minimally Invasive Surgical Treatment for Benign Prostatic Hyperplasia: A Systematic Review and Analysis of Comparative Outcomes. Uro-technology and SoMe Working Group of the Young Academic Urologists Working Party of the European Association of Urology and of the Lower Tract and Research Group of the European Section of Uro-technology. Eur Urol Open Sci. 2021 Sep 22; 33: 28–41.Righetto M, Mancini M, Modonutti D, Calpista A, Beltrami P, Dal Moro F. Patients with renal transplant and moderate-to-severe LUTS benefit from urodynamic evaluation and early transurethral resection of the prostate. World J Urol. 2021 Dec; 39 (12): 4397–4404.Righetto M, Mancini M, Modonutti D, Calpista A, Beltrami P, Dal Moro F. Patients with renal transplant and moderate-to-severe LUTS benefit from urodynamic evaluation and early transurethral resection of the prostate. World J Urol. 2021 Dec; 39 (12): 4397–4404.Sarier M, Tekin S, Duman İ, Yuksel Y, Demir M, Alptekinkaya F et al. Results of transurethral resection of the prostate in renal transplant recipients: a single center experience. World J Urol. 2018 Jan; 36 (1): 99–103.Sarier M, Tekin S, Duman İ, Yuksel Y, Demir M, Alptekinkaya F et al. Results of transurethral resection of the prostate in renal transplant recipients: a single center experience. World J Urol. 2018 Jan; 36 (1): 99–103.Rassweiler J, Teber D, Kuntz R et al. Complications of transurethral resection of the prostate (TURP) dincidence, management, and prevention. Eur Urol. 2006; 50: 969.Rassweiler J, Teber D, Kuntz R et al. Complications of transurethral resection of the prostate (TURP) dincidence, management, and prevention. Eur Urol. 2006; 50: 969.Liu Z, Li YW, Wu WR et al. Long-term clinicale fficacy and safety profile of transurethral resection of prostate versus plasma kinetic resection of the prostate for benign prostatic hyperplasia. Urology. 2017; 103: 198.Liu Z, Li YW, Wu WR et al. Long-term clinicale fficacy and safety profile of transurethral resection of prostate versus plasma kinetic resection of the prostate for benign prostatic hyperplasia. Urology. 2017; 103: 198.Friedl A, Schneeweiss J, Stangl K et al. The adjustable transobturator male system in stress urinary incontinence after transurethral resection of the prostate. Urology. 2017; 109: 184.Friedl A, Schneeweiss J, Stangl K et al. The adjustable transobturator male system in stress urinary incontinence after transurethral resection of the prostate. Urology. 2017; 109: 184.Boston Scientific Corporation: Intended use. Rezum Instruction for Use, 10-2019; 5.Boston Scientific Corporation: Intended use. Rezum Instruction for Use, 10-2019; 5.Dixon CM, Rijo Cedano E, Mynderse LA et al. Transurethral convective water vapor as atreatment for lower urinary tract symptom-atology due to benign prostatic hyperplasiausing the Rezum(R) system: evaluation of acuteablative capabilities in the human prostate. Res Rep Urol. 2015; 7: 13.Dixon CM, Rijo Cedano E, Mynderse LA et al. Transurethral convective water vapor as atreatment for lower urinary tract symptom-atology due to benign prostatic hyperplasiausing the Rezum(R) system: evaluation of acuteablative capabilities in the human prostate. Res Rep Urol. 2015; 7: 13.Bouza C, Lopez T, Magro A et al. Systematic review and meta-analysis of transurethral needle ablation in symptomatic benign prostatic hyperplasia. BMC Urol. 2006; 6: 14.Bouza C, Lopez T, Magro A et al. Systematic review and meta-analysis of transurethral needle ablation in symptomatic benign prostatic hyperplasia. BMC Urol. 2006; 6: 14.McVary KT, Rogers T, Mahon J et al. Is sexual function better preserved after water vapor thermal therapy or medical therapy for lower urinary tract symptoms due to benign prostatic hyperplasia? J Sex Med. 2018; 15: 1728.McVary KT, Rogers T, Mahon J et al. Is sexual function better preserved after water vapor thermal therapy or medical therapy for lower urinary tract symptoms due to benign prostatic hyperplasia? J Sex Med. 2018; 15: 1728.National Institute for Health and Care Excellence: Rezum for treating lower urinary tractsymptoms secondary to benign prostatic hyperplasia (24 June 2020). NICE Guideline No. MTG49.National Institute for Health and Care Excellence: Rezum for treating lower urinary tractsymptoms secondary to benign prostatic hyperplasia (24 June 2020). NICE Guideline No. MTG49.Mynderse LA, Roehrborn CG, Partin AW et al. Results of a 5-year multicenter trial of a new generation cooled high energy transurethral microwave thermal therapy catheter for benign prostatic hyperplasia. J Urol. 2011; 185: 1804.Mynderse LA, Roehrborn CG, Partin AW et al. Results of a 5-year multicenter trial of a new generation cooled high energy transurethral microwave thermal therapy catheter for benign prostatic hyperplasia. J Urol. 2011; 185: 1804.Gravas S, Cornu JN, Gacci M et al. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction. Arnhem, The Netherlands: EAU Guidelines Office. 2020.Gravas S, Cornu JN, Gacci M et al. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction. Arnhem, The Netherlands: EAU Guidelines Office. 2020.McVary KT, Rogers T, Roehrborn CG. Rezum water vapor thermal therapy for lower urinarytract symptoms associated with benign prostatichyperplasia: 4-year results from randomized controlled study. Urology. 2019; 126: 171.McVary KT, Rogers T, Roehrborn CG. Rezum water vapor thermal therapy for lower urinarytract symptoms associated with benign prostatichyperplasia: 4-year results from randomized controlled study. Urology. 2019; 126: 171.McVary KT, Roehrborn CG. Three-year out-comes of the prospective, randomized controlled Rezum System Study: convective radio frequency thermal therapy for treatment of lower urinarytract symptoms due to benign prostatic hyperplasia. Urology. 2018; 111: 1.McVary KT, Roehrborn CG. Three-year out-comes of the prospective, randomized controlled Rezum System Study: convective radio frequency thermal therapy for treatment of lower urinarytract symptoms due to benign prostatic hyperplasia. Urology. 2018; 111: 1.U.S. Food and Drug Administration: Select Up-dates for Guidance for the Non-Clinical and Clinical Investigation of Devices Used for the Treatment of Benign Prostatic Hyperplasia (BPH): Draft Guidance for Industry and Food and Drug Administration Staff (July 14, 2020).U.S. Food and Drug Administration: Select Up-dates for Guidance for the Non-Clinical and Clinical Investigation of Devices Used for the Treatment of Benign Prostatic Hyperplasia (BPH): Draft Guidance for Industry and Food and Drug Administration Staff (July 14, 2020).Roehrborn CG, Wilson TH, Black LK. Quantifying the contribution of symptom improvement to satisfaction of men with moderate to severe benign prostatic hyperplasia: 4-year data from the CombAT trial. J Urol. 2012; 187: 1732.Roehrborn CG, Wilson TH, Black LK. Quantifying the contribution of symptom improvement to satisfaction of men with moderate to severe benign prostatic hyperplasia: 4-year data from the CombAT trial. J Urol. 2012; 187: 1732.Miller LE, Chughtai B, Dornbier RA et al. Surgical reintervention rate after prostatic urethral lift: systematic review and meta-analysis involving over 2,000 patients. J Urol. 2020; 204: 1019.Miller LE, Chughtai B, Dornbier RA et al. Surgical reintervention rate after prostatic urethral lift: systematic review and meta-analysis involving over 2,000 patients. J Urol. 2020; 204: 1019.Roehrborn CG, Barkin J, Gange SN et al. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol. 2017; 24: 8802.Roehrborn CG, Barkin J, Gange SN et al. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol. 2017; 24: 8802.Zlotta AR, Giannakopoulos X, Maehlum O et al. Longterm evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centers. Eur Urol. 2003; 44: 89.Zlotta AR, Giannakopoulos X, Maehlum O et al. Longterm evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centers. Eur Urol. 2003; 44: 89.Rosario DJ, Phillips JT, Chapple CR. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails. J Urol. 2007; 177: 1047.Rosario DJ, Phillips JT, Chapple CR. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails. J Urol. 2007; 177: 1047.Hill B, Belville W, Bruskewitz R et al. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol. 2004; 171: 2336.Hill B, Belville W, Bruskewitz R et al. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol. 2004; 171: 2336.Gupta N, Rogers T, Holland B et al. Three-year treatment outcomes of water vapor thermal therapy compared to doxazosin, finasteride and combination drug therapy in men with benign prostatic hyperplasia: cohort data from the MTOPS trial. J Urol. 200; 405: 2018.Gupta N, Rogers T, Holland B et al. Three-year treatment outcomes of water vapor thermal therapy compared to doxazosin, finasteride and combination drug therapy in men with benign prostatic hyperplasia: cohort data from the MTOPS trial. J Urol. 200; 405: 2018.Malde S, Rajagopalan A, Patel N et al. Potassium-titanyl-phosphate laser photoselective vaporization for benign prostatic hyperplasia: 5-year follow-up from a district general hospital. J Endourol. 2012; 26: 878.Malde S, Rajagopalan A, Patel N et al. Potassium-titanyl-phosphate laser photoselective vaporization for benign prostatic hyperplasia: 5-year follow-up from a district general hospital. J Endourol. 2012; 26: 878.Lee HE, Kim B, Yoon HS, Suh J, Oh SJ. Outcome of Patients With Elevated Prostate-Specific Antigen and Lower Urinary Tract Symptoms Receiving Holmium Laser Enucleation of the Prostate. Int Neurourol J. 2022 Sep; 26 (3): 248–257.Lee HE, Kim B, Yoon HS, Suh J, Oh SJ. Outcome of Patients With Elevated Prostate-Specific Antigen and Lower Urinary Tract Symptoms Receiving Holmium Laser Enucleation of the Prostate. Int Neurourol J. 2022 Sep; 26 (3): 248–257.Takeuchi Y, Sawada Y, Watanabe S, Ni­Itsu Y, Sekido N. Age-specific effect of transurethral holmium laser enucleation of the prostate on overactive bladder in men with benign prostatic hyperplasia: An investigation using an overactive bladder symptom score. Low Urin Tract Symptoms. 2022 Dec 11.Takeuchi Y, Sawada Y, Watanabe S, Ni­Itsu Y, Sekido N. Age-specific effect of transurethral holmium laser enucleation of the prostate on overactive bladder in men with benign prostatic hyperplasia: An investigation using an overactive bladder symptom score. Low Urin Tract Symptoms. 2022 Dec 11.Nohara T, Matsuyama S, Shima T, Kawaguchi S, Seto C. Holmium Laser Enucleation of the Prostate With Percutaneous Nephrostomy Into the Transplanted Kidney in Patient With Severe Benign Prostatic Hyperplasia With Vesicoureteral Reflux – A Case Report. Urol Case Rep. 2015 Dec 10; 4: 33–35.Nohara T, Matsuyama S, Shima T, Kawaguchi S, Seto C. Holmium Laser Enucleation of the Prostate With Percutaneous Nephrostomy Into the Transplanted Kidney in Patient With Severe Benign Prostatic Hyperplasia With Vesicoureteral Reflux – A Case Report. Urol Case Rep. 2015 Dec 10; 4: 33–35.Prudhomme T, Marquette T, Péré M. Benign Prostatic Hyperplasia Endoscopic Surgical Procedures in Kidney Transplant Recipients: A Comparison Between Holmium Laser Enucleation of the Prostate, GreenLight Photoselective Vaporization of the Prostate, and Transurethral Resection of the Prostate. J Endourol. 2020 Feb; 34 (2): 184–191.Prudhomme T, Marquette T, Péré M. Benign Prostatic Hyperplasia Endoscopic Surgical Procedures in Kidney Transplant Recipients: A Comparison Between Holmium Laser Enucleation of the Prostate, GreenLight Photoselective Vaporization of the Prostate, and Transurethral Resection of the Prostate. J Endourol. 2020 Feb; 34 (2): 184–191.Baboudjian M, Fourmarier M, Gondran­Tellier B, Pradere B, Userovici M, Alegorides C, Barry Delongchamps N. Head-to-head comparison of prostatic urethral lift and water vapor thermal therapy for the treatment of symptomatic benign prostatic hyperplasia: a real-life study. Int Urol Nephrol. 2021 Sep; 53 (9): 1757–1763.Baboudjian M, Fourmarier M, Gondran­Tellier B, Pradere B, Userovici M, Alegorides C, Barry Delongchamps N. Head-to-head comparison of prostatic urethral lift and water vapor thermal therapy for the treatment of symptomatic benign prostatic hyperplasia: a real-life study. Int Urol Nephrol. 2021 Sep; 53 (9): 1757–1763.Alexander CE, Scullion MM, Omar MI, Yuan Y, Mamoulakis C, N’Dow JM et al. Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction. Cochrane Database Syst Rev. 2019 Dec 3; 12 (12): CD009629.Alexander CE, Scullion MM, Omar MI, Yuan Y, Mamoulakis C, N’Dow JM et al. Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction. Cochrane Database Syst Rev. 2019 Dec 3; 12 (12): CD009629.Mamoulakis C, Ubbink DT, de la Rosette JJ. Bipolar versus monopolar transurethral resection of the prostate: A systematic review and meta-analysis of randomized controlled trials. Eur Urol. 2009; 56: 798–809. doi: 10.1016/j.eururo.2009.06.037.Mamoulakis C, Ubbink DT, de la Rosette JJ. Bipolar versus monopolar transurethral resection of the prostate: A systematic review and meta-analysis of randomized controlled trials. Eur Urol. 2009; 56: 798–809. doi: 10.1016/j.eururo.2009.06.037.Ahyai SA, Gilling P, Kaplan SA et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010; 58: 384–397.Ahyai SA, Gilling P, Kaplan SA et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010; 58: 384–397.Burke N, Whelan JP, Goeree L et al. Systematic review and meta-analysis of transurethral resection of the prostate vs. minimally invasive procedures for the treatment of benign prostatic obstruction. Urology. 2010; 75: 1015–1022.Burke N, Whelan JP, Goeree L et al. Systematic review and meta-analysis of transurethral resection of the prostate vs. minimally invasive procedures for the treatment of benign prostatic obstruction. Urology. 2010; 75: 1015–1022.Omar MI, Lam TBL, Cameron A et al. Systematic review and meta-analysis of the clinical effectiveness of bipolar compared to monopolar transurethral resection of the prostate. BJU Int. 2014; 113: 24–35.Omar MI, Lam TBL, Cameron A et al. Systematic review and meta-analysis of the clinical effectiveness of bipolar compared to monopolar transurethral resection of the prostate. BJU Int. 2014; 113: 24–35.Cornu JN, Ahyai S, Bachmann A et al. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: An update. Eur Urol. 2015; 67: 1066–1096.Cornu JN, Ahyai S, Bachmann A et al. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: An update. Eur Urol. 2015; 67: 1066–1096.Mamoulakis C, Sofras F, de la Rosette J et al. Bipolar vs. monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction. Cochrane Database Syst Rev. 2014; 1: CD009629.Mamoulakis C, Sofras F, de la Rosette J et al. Bipolar vs. monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction. Cochrane Database Syst Rev. 2014; 1: CD009629.Taylor BL, Jaffe WI. Electrosurgical transurethral resection of the prostate and transurethral incision of the prostate (monopolar techniques). Can J Urol. 2015 Oct; 22 Suppl 1: 24–29.Taylor BL, Jaffe WI. Electrosurgical transurethral resection of the prostate and transurethral incision of the prostate (monopolar techniques). Can J Urol. 2015 Oct; 22 Suppl 1: 24–29.Sarıer M, Duman İ, Demir M, Yüksel Y, Emek M, Kukul E. The outcomes of transurethral incision/resection of the prostate (TUIP/TURP) performed early afterrenal transplantation. Turk J Urol. 2018 Mar; 44 (2): 172–177.Sarıer M, Duman İ, Demir M, Yüksel Y, Emek M, Kukul E. The outcomes of transurethral incision/resection of the prostate (TUIP/TURP) performed early afterrenal transplantation. Turk J Urol. 2018 Mar; 44 (2): 172–177.Sarier M, Duman I, Kilic S, Yuksel Y, Demir M, Aslan M et al. Comparative Results of Transurethral Incision with Transurethral Resection of The Prostate in Renal Transplant Recipients with Benign Prostate Hyperplasia. Urol J. 2018 Jul 10; 15 (4): 209–213.Sarier M, Duman I, Kilic S, Yuksel Y, Demir M, Aslan M et al. Comparative Results of Transurethral Incision with Transurethral Resection of The Prostate in Renal Transplant Recipients with Benign Prostate Hyperplasia. Urol J. 2018 Jul 10; 15 (4): 209–213.Duty BD, Conlin MJ, Fuchs EF, Barry JM. The current role of endourologic management of renal transplantation complications. Adv Urol. 2013; 2013: 246520.Duty BD, Conlin MJ, Fuchs EF, Barry JM. The current role of endourologic management of renal transplantation complications. Adv Urol. 2013; 2013: 246520.Cardi A, Palleschi G, Patruno G, Tuffu G, D’Amico FE, De Vico A et al. Robot-assisted simple prostatectomy for treatment of large prostatic adenomas: surgical technique and outcomes from a high-volume robotic centre. World J Urol. 2022 Dec 25.Cardi A, Palleschi G, Patruno G, Tuffu G, D’Amico FE, De Vico A et al. Robot-assisted simple prostatectomy for treatment of large prostatic adenomas: surgical technique and outcomes from a high-volume robotic centre. World J Urol. 2022 Dec 25.Law YXT, Chen WJK, Shen L, Chua WJ. Is transurethral needle ablation of prostate out of fashion? Outcomes of single session office-based transurethral needle ablation of prostate in patients with symptomatic benign prostatic hyperplasia. Investig Clin Urol. 2019 Sep; 60 (5): 351–358.Law YXT, Chen WJK, Shen L, Chua WJ. Is transurethral needle ablation of prostate out of fashion? Outcomes of single session office-based transurethral needle ablation of prostate in patients with symptomatic benign prostatic hyperplasia. Investig Clin Urol. 2019 Sep; 60 (5): 351–358.Powell T, Rahman S, Staib L, Bhatia S, Ayyagari R. Operator Learning Curve for Prostatic Artery Embolization and Its Impact on Outcomes in 296 Patients. Cardiovasc Intervent Radiol. 2022 Dec 1.Powell T, Rahman S, Staib L, Bhatia S, Ayyagari R. Operator Learning Curve for Prostatic Artery Embolization and Its Impact on Outcomes in 296 Patients. Cardiovasc Intervent Radiol. 2022 Dec 1.Goyal P, Salem R, Mouli SK. Controversies in Prostate Artery Embolization: Future Best Practice. Semin Intervent Radiol. 2022 Dec 20; 39 (6): 562–570.Goyal P, Salem R, Mouli SK. Controversies in Prostate Artery Embolization: Future Best Practice. Semin Intervent Radiol. 2022 Dec 20; 39 (6): 562–570.Gondran­Tellier B, McManus R, Sichez PC, Akiki A, Gaillet S, Toledano H et al. Efficacy and Safety of Surgery for Benign Prostatic Obstruction in Patients with Preoperative Urinary Catheter. J Endourol. 2021 Jan; 35 (1): 102–108.Gondran­Tellier B, McManus R, Sichez PC, Akiki A, Gaillet S, Toledano H et al. Efficacy and Safety of Surgery for Benign Prostatic Obstruction in Patients with Preoperative Urinary Catheter. J Endourol. 2021 Jan; 35 (1): 102–108.Яремин БИ, Харитонов БИ, Миронов АА, Масликова УВ, Александрова ВЭ. Трансплантация почки – поиск оптимальной хирургической техники. Вестник медицинского института «РЕАВИЗ». 2017; (5): 94–104.Yaremin BI, Kharitonov BI, Mironov AA, Maslikova UV, Aleksandrova VE. Transplantatsiya pochki – poisk optimal’noy khirurgicheskoy tekhniki. Vestnik meditsinskogo instituta «REAVIZ». 2017; (5): 94–104.Chadban SJ, Ahn C, Axelrod DA, Foster BJ, Kasiske BL, Kher V et al. KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation. Transplantation. 2020 Apr; 104 (4S1 Suppl 1): S11–S103.Chadban SJ, Ahn C, Axelrod DA, Foster BJ, Kasiske BL, Kher V et al. KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation. Transplantation. 2020 Apr; 104 (4S1 Suppl 1): S11–S103.Choudhury S, Haldar B, Pal DK. Spectrum of lower urinary tract symptoms after renal transplant among adult non-urologic anuric patients and their management in a tertiary care center. Urologia. 2022 Feb 3: 3915603211048150. doi: 10.1177/03915603211048150.Choudhury S, Haldar B, Pal DK. Spectrum of lower urinary tract symptoms after renal transplant among adult non-urologic anuric patients and their management in a tertiary care center. Urologia. 2022 Feb 3: 3915603211048150. doi: 10.1177/03915603211048150.Клинические рекомендации Европейской ассоциации урологов [Электронный ресурс]. М.: Медконгресс, 2019; 1368.Klinicheskie rekomendatsii Evropeyskoy assotsiatsii urologov [Elektronnyy resurs]. M.: Medkongress, 2019; 1368.Интегративная урология. Руководство для врачей / Под ред. П.В. Глыбочко, Ю.Г. Аляева. М.: Медфорум, 2014: 128–239, 314–326.Integrativnaya urologiya. Rukovodstvo dlya vrachey / Pod red. P.V. Glybochko, Yu.G. Alyaeva. M.: Medforum, 2014: 128–239, 314–326.na P, Baboudjian M, Piana A, Girón I et al. New Generation Pulse Modulation in Holmium:YAG Lasers: A Systematic Review of the Literature and Meta-Analysis. J Clin Med. 2022 Jun 4; 11 (11): 3208.Sánchez­Puy A, Bravo­Balado A, Diana P, Baboudjian M, Piana A, Girón I et al. New Generation Pulse Modulation in Holmium:YAG Lasers: A Systematic Review of the Literature and Meta-Analysis. J Clin Med. 2022 Jun 4; 11 (11): 3208.Perri A, Izzo G, Lofaro D, La Vignera S, Brunetti A, Calogero AE, Aversa A. Erectile Dysfunction after Kidney Transplantation. J Clin Med. 2020 Jun 25; 9 (6): 1991.Perri A, Izzo G, Lofaro D, La Vignera S, Brunetti A, Calogero AE, Aversa A. Erectile Dysfunction after Kidney Transplantation. J Clin Med. 2020 Jun 25; 9 (6): 1991.Kleinclauss F, Thuret R, Murez T, Timsit MO. Urologic malignancies in renal transplant candidates and recipients. Prog Urol. 2016 Nov; 26 (15): 1094–1113.Kleinclauss F, Thuret R, Murez T, Timsit MO. Urologic malignancies in renal transplant candidates and recipients. Prog Urol. 2016 Nov; 26 (15): 1094–1113.Данович МГ. Трансплантация почки. Пер. с англ. под ред. Я.Г. Мойсюка. М.: ГЭОТАР Медиа, 2014; 848.Danovich MG. Transplantatsiya pochki. Per. s angl. pod red. Ya.G. Moysyuka. M.: GEOTAR Media, 2014; 848.Latchamsetty KC, Mital D, Jensik S. Use of collagen injections for vesicoureteral reflux in transplanted kidney. Transplant Proc. 2003; 35: 1378.Latchamsetty KC, Mital D, Jensik S. Use of collagen injections for vesicoureteral reflux in transplanted kidney. Transplant Proc. 2003; 35: 1378.Li Marzi V, Filocamo MT, Dattolo E. The treatment of fistulae and ureteral stenosis after kidney transplantation. Transplant Proc. 2005; 37: 2516.Li Marzi V, Filocamo MT, Dattolo E. The treatment of fistulae and ureteral stenosis after kidney transplantation. Transplant Proc. 2005; 37: 2516.Mokos I, Kastelan Z, Basić­Jukić N, Kes P, Pasini J. Transurethral incision/resection of the prostate (TUIP/ TURP) in operative treatment of repeated bladder outlet obstruction early after kidney transplantation. Acta Clin Croat. 2011 Sep; 50 (3): 381–384.Mokos I, Kastelan Z, Basić­Jukić N, Kes P, Pasini J. Transurethral incision/resection of the prostate (TUIP/ TURP) in operative treatment of repeated bladder outlet obstruction early after kidney transplantation. Acta Clin Croat. 2011 Sep; 50 (3): 381–384.Védrine N, Nsabimbona B, Soares P, Deteix P, Boiteux JP, Guy L. Transurethral resection or incision of the prostate in the immediate postoperative follow-up of renal transplantation. Prog Urol. 2009 Dec; 19 (11): 845–849.Védrine N, Nsabimbona B, Soares P, Deteix P, Boiteux JP, Guy L. Transurethral resection or incision of the prostate in the immediate postoperative follow-up of renal transplantation. Prog Urol. 2009 Dec; 19 (11): 845–849.Gratzke C, Pahde A, Dickmann M, Reich O, Seitz M, Jauch K et al. Predictive factors for urinary retention following kidney transplantation in male patients. Scand J Urol Nephrol. 2012 Feb; 46 (1): 44–47.Gratzke C, Pahde A, Dickmann M, Reich O, Seitz M, Jauch K et al. Predictive factors for urinary retention following kidney transplantation in male patients. Scand J Urol Nephrol. 2012 Feb; 46 (1): 44–47.Gill BC, Ulchaker JC. Costs of managing benign prostatic hyperplasia in the office and operating room. Curr Urol Rep. 2018; 19: 72.Gill BC, Ulchaker JC. Costs of managing benign prostatic hyperplasia in the office and operating room. Curr Urol Rep. 2018; 19: 72.

The authors declare that there are no conflicts of interest present.